Pazopanib hydrochlorideProduct ingredient for Pazopanib

Name: Pazopanib hydrochloride
Drug Entry: Pazopanib

Pazopanib is a small molecule inhibitor of multiple protein tyrosine kinases with potential antineoplastic activity. It is developed by GlaxoSmithKline and was FDA approved on October 19, 2009.

See full entry for Pazopanib
Accession Number: DBSALT000135
Structure: MOL SDF PDB SMILES InChI
Structure for Pazopanib hydrochloride (DBSALT000135)
Synonyms: Pazopanib HCl
External IDs: GW 786034B / GW-786034B / GW786034B